A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials (Q4665957)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials |
scientific article; zbMATH DE number 2155396
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials |
scientific article; zbMATH DE number 2155396 |
Statements
A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials (English)
0 references
11 April 2005
0 references
Bayesian inference
0 references
clinical trial
0 references
dose-finding studies
0 references
phase I trial
0 references
phase II trial
0 references
safety monitoring
0 references
